Companies
- Companies
- Browse
Companies
The core technology of FAB is based on a new class of patented biopolymers obtained from chemical modifications of hyaluronan More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 952 pages - $2,495
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Nov 2011 - 7 pages - $75
Sep 2007 - 18 pages - $1,695
Jan 2009 - 14 pages - $1,695
Dec 2009 - 10 pages - $1,695
May 2011 - 15 pages - $250
Mar 2009 - 14 pages - $500
Oct 2010 - 72 pages - $3,500
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Accident & Trauma (other)
- Back Pain
- Bone fractures
- Burns
- CNS trauma
- Drug overdose
- Hemorraghic trauma
- Muscle sprain/strain
- Poisioning
- Reperfusion injury (lung/heart)
- Stroke/traumatic brain injury
- Tissue grafting
- Wound closure/surgical adhesive
- Wound/ulcer healing
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us